These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 21598248)
1. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression. Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248 [TBL] [Abstract][Full Text] [Related]
2. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Rajan N; Elliott R; Clewes O; Mackay A; Reis-Filho JS; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A Oncogene; 2011 Oct; 30(41):4243-60. PubMed ID: 21552290 [TBL] [Abstract][Full Text] [Related]
3. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells. Rajan N; Andersson MK; Sinclair N; Fehr A; Hodgson K; Lord CJ; Kazakov DV; Vanecek T; Ashworth A; Stenman G J Pathol; 2016 Jun; 239(2):197-205. PubMed ID: 26969893 [TBL] [Abstract][Full Text] [Related]
5. Inherited cylindromas: lessons from a rare tumour. Rajan N; Ashworth A Lancet Oncol; 2015 Sep; 16(9):e460-e469. PubMed ID: 26370355 [TBL] [Abstract][Full Text] [Related]
6. CYLD tidies up dishevelled signaling. Komander D Mol Cell; 2010 Mar; 37(5):589-90. PubMed ID: 20227361 [TBL] [Abstract][Full Text] [Related]
7. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling. Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691 [TBL] [Abstract][Full Text] [Related]
8. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma. Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826 [TBL] [Abstract][Full Text] [Related]
9. Spiradenocylindrocarcinoma: a malignant hybrid tumor. Carlsten JR; Lewis MD; Saddler K; Reilly P; Pan T; Gnepp DR; Robinson-Bostom L J Cutan Pathol; 2005 Feb; 32(2):166-71. PubMed ID: 15606677 [TBL] [Abstract][Full Text] [Related]
10. Carcinoma ex spiradenoma/cylindroma confirmed by immunohistochemical and molecular loss-of-heterozygosity profiling. Jukic DM; Drogowski LM; Davie JR Am J Dermatopathol; 2009 Oct; 31(7):702-8. PubMed ID: 19684510 [TBL] [Abstract][Full Text] [Related]
11. Spiradenocylindromas of the skin: tumors with morphological features of spiradenoma and cylindroma in the same lesion: report of 12 cases. Michal M; Lamovec J; Mukensnabl P; Pizinger K Pathol Int; 1999 May; 49(5):419-25. PubMed ID: 10417685 [TBL] [Abstract][Full Text] [Related]
12. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer. Mu J; Hui T; Shao B; Li L; Du Z; Lu L; Ye L; Li S; Li Q; Xiao Q; Qiu Z; Zhang Y; Fan J; Ren G; Tao Q; Xiang T Oncotarget; 2017 Jun; 8(24):39443-39459. PubMed ID: 28467796 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219 [TBL] [Abstract][Full Text] [Related]
14. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma and eccrine spiradenoma. Chen M; Liu H; Fu X; Yu Y; Yu G; Tian H; Zhou G; Lu X; Chen S Int J Dermatol; 2013 Dec; 52(12):1602-4. PubMed ID: 24261740 [No Abstract] [Full Text] [Related]
15. Cylindroma and eccrine spiradenoma coexistent in the same lesion. Goette DK; McConnell MA; Fowler VR Arch Dermatol; 1982 Apr; 118(4):274-4. PubMed ID: 6279036 [TBL] [Abstract][Full Text] [Related]
16. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission. Arefi M; Wilson V; Muthiah S; Zwolinski S; Bajwa D; Brennan P; Blasdale K; Bourn D; Burn J; Santibanez-Koref M; Rajan N J Am Acad Dermatol; 2019 Dec; 81(6):1300-1307. PubMed ID: 31085270 [TBL] [Abstract][Full Text] [Related]
17. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers. Sellheyer K J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097 [TBL] [Abstract][Full Text] [Related]
18. [Multiple trichoepithelioma, cylindroma, eccrine spiradenoma present in the same family. Histologic and histopathogenetic considerations]. Cecchi R; Crudeli F; Fedi E; Giomi A G Ital Dermatol Venereol; 1985; 120(2):149-52. PubMed ID: 2989163 [No Abstract] [Full Text] [Related]
19. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome. Kazakov DV; Grossmann P; Spagnolo DV; Vanecek T; Vazmitel M; Kacerovska D; Zelger B; Calonje E; Michal M Am J Dermatopathol; 2010 May; 32(3):215-221. PubMed ID: 20075707 [TBL] [Abstract][Full Text] [Related]
20. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis. Bell AH; Prieto VG; Ferrarotto R; Goepfert RP; Myers JN; Weber R; Bell D Ann Diagn Pathol; 2019 Aug; 41():14-23. PubMed ID: 31128548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]